Morphological control as well as formation of nanoparticles of anatase-type titanium dioxide has been achieved by a solvothermal treatment of a water-soluble citratoperoxotitanium (CPT) complex using ethylenediamine (EDA) as a key solvent in the presence of a given amount of water. When the EDA concentration in the whole solvent (EDA + H2O) remained low less than 12 M, the powder obtained after the solvothermal treatment consisted of spindle-like anatase particles. With an increase of the EDA concentration in the solvent, the shape of the obtained particles changed from spindle to square bipyramid. When another water-soluble oxoglycolatoperoxotitanate complex or TiCl4 was used as a starting source of Ti, similar shaped anatase particles could be obtained by a careful choice of synthetic conditions. Using a mixed solvent of EDA and water, sheet-like titanic acid was produced as an intermediate phase, regardless of the EDA concentration. Therefore, the formation of anatase in the current system may take place through dissolution-recrystallization of titanic acid. The formation of square bipyramidal anatase particle achieved in the present study is not agreement with a reported theoretical calculation of equilibrium phase, because the calculation reveals that truncated square bipyramid-like anatase is obtained under an acidic condition and spindle-like anatase was formed under a basic condition. An adsorption of EDA on particle surface and the pH of the solvent may contribute to the achievement of morphological control.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: